In this review, we highlight the role of pneumoproteins, namely Krebs von den Lungen-6 (KL-6), surfactant proteins (SP-A, SP-B, SP-C, SP-D), and Clara cell secretory protein (CC16), as potential pulmonary biomarkers for COVID-19-associated lung injury. This evidence concerns the gene MUC1 and COVID-19.